Breaking News

MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development

Both companies will collaborate to develop innovative applications of the CELL HANDLER in combination with MIMETAS’ 3D tissue models

Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon

China's National Medical Products Administration (NMPA) has approved Nefecon for the treatment of primary immunoglobulin A nephropathy (IgAN) in ad...

CN Bio wins "Most Impactful Industry Collaboration of the Year" at the OBN Awards

Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption...

The roadmap to success in the cannabinoid drug development journey

The key to success in the development and registration of cannabinoid-based medicines hinges on choosing a GMP-certified high-purity active ingredi...

New capital strengthens ProtaGene's advanced analytical leadership in the biologics and CGT markets

ProtaGene GmbH, a leading global contract research organization (CRO) dedicated to advanced analytics for biologics and cell and gene therapies, an...

CatSci expands capabilities to offer expert cGMP analytical development services

CatSci is thrilled to announce the launch of its expert cGMP analytical capabilities in Dagenham, UK

Diagnosing hormone-based disorders using saliva

Diagnosing hormone-based disorders using saliva samples dates back to the 1980s; however, it’s only the sensitivity improvements that have occurred...

How to proactively address EU HTAR implementation challenges before 2025

Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of...

Symbiosis Pharmaceutical Services granted MHRA licence following a £1m investment

Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biolo...

Xybion acquires Autoscribe Informatics to expand its LIMS business

Xybion Corporation is pleased to announce the acquisition of Autoscribe Informatics. This represents a significant strategic expansion in the compa...

The right validation model: practical considerations and applications

It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model...

Adding more to the cell and gene therapy playbook

With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanopartic...

More than 3000 cacti send a clear message for sustainable lab practices

More than 3000 cacti have been planted in Starlab TipOne racks as a daily reminder to laboratory scientists to put sustainability at the core of th...

Analytical method development in a high potent facility

Analytical method development is a cornerstone of pharmaceutical outsourcing. In this Q&A with Dr Kevin Robinson (KSR), Amanda Blackwell (AB), Head...

TÜV Rheinland is now a UK approved body according to UK MDR

TÜV Rheinland has been designated by the UK competent authority “Medicines and Healthcare products Regulatory Agency” to do UKCA certification in a...

Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment

In this article, Dr Chantale Bernatchez, Director of Process Development at CTMC, highlights the need for a standardised TIL manufacturing process...

Most Popular

  1. SK pharmteco subsidiary Yposkesi launches AAVelocity, a plug-and-play AAV platform
  2. How self-replicating RNA can transform in vitro-transcribed drug development
  3. Spray drying: taking the heat out of processing sensitive products
  4. Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon
  5. More than 3000 cacti send a clear message for sustainable lab practices

Inspiration and Learning

Manufacturing Chemist Stand Side with ACG
Manufacturing Chemist Stand Side with ACG
Manufacturing Chemist Stand Side with Lonza
Manufacturing Chemist Stand Side with Lonza
Manufacturing Chemist Stand Side with Piramal Pharma Solutions
Manufacturing Chemist Stand Side with Piramal Pharma Solutions
Manufacturing Chemist Stand Side with Syntegon
Manufacturing Chemist Stand Side with Syntegon
Manufacturing Chemist Stand Side with C2 Pharma
Manufacturing Chemist Stand Side with C2 Pharma
Manufacturing Chemist Stand Side with Almac
Manufacturing Chemist Stand Side with Almac
Enteric delivery of my API: how to make it right?
Enteric delivery of my API: how to make it right?
Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Cleaning validation and verification in a high potent granulation suite
Cleaning validation and verification in a high potent granulation suite
Manufacturing Chemist in conversation with Cytiva
Manufacturing Chemist in conversation with Cytiva

Careers

Reports

The roadmap to success in the cannabinoid drug development journey
The roadmap to success in the cannabinoid drug development journey
Diagnosing hormone-based disorders using saliva
Diagnosing hormone-based disorders using saliva
The right validation model: practical considerations and applications
The right validation model: practical considerations and applications
Analytical method development in a high potent facility
Analytical method development in a high potent facility
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Simplifying technology transfer to get drugs to market faster
Simplifying technology transfer to get drugs to market faster
Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics
Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics
What’s in a partner? The essential facets of a strong biopharma collaboration
What’s in a partner? The essential facets of a strong biopharma collaboration
How self-replicating RNA can transform in vitro-transcribed drug development
How self-replicating RNA can transform in vitro-transcribed drug development
Overcoming cell separation challenges to advance stem cell therapy research
Overcoming cell separation challenges to advance stem cell therapy research